Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood Asthma

Hernandez-Pacheco, Natalia and Gorenjak, Mario and Li, Jiang and Repnik, Katja and Vijverberg, Susanne J. and Berce, Vojko and Jorgensen, Andrea and Karimi, Leila and Schieck, Maximilian and Samedy-Bates, Lesly-Anne and Tavendale, Roger and Villar, Jesus and Mukhopadhyay, Somnath and Pirmohamed, Munir and Verhamme, Katia M. C. and Kabesch, Michael and Hawcutt, Daniel B. and Turner, Steve and Palmer, Colin N. and Tantisira, Kelan G. and Burchard, Esteban G. and Maitland-van der Zee, Anke H. and Flores, Carlos and Potocnik, Uros and Pino-Yanes, Maria (2021) Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood Asthma. JOURNAL OF PERSONALIZED MEDICINE, 11 (8): 733. ISSN , 2075-4426

Full text not available from this repository. (Request a copy)

Abstract

Inhaled corticosteroids (ICS) are the most common asthma controller medication. An important contribution of genetic factors in ICS response has been evidenced. Here, we aimed to identify novel genetic markers involved in ICS response in asthma. A genome-wide association study (GWAS) of the change in lung function after 6 weeks of ICS treatment was performed in 166 asthma patients from the SLOVENIA study. Patients with an improvement in lung function >= 8% were considered as ICS responders. Suggestively associated variants (p-value <= 5 x 10(-6)) were evaluated in an independent study (n = 175). Validation of the association with asthma exacerbations despite ICS use was attempted in European (n = 2681) and admixed (n = 1347) populations. Variants previously associated with ICS response were also assessed for replication. As a result, the SNP rs1166980 from the ROBO2 gene was suggestively associated with the change in lung function (OR for G allele: 7.01, 95% CI: 3.29-14.93, p = 4.61 x 10(-7)), although this was not validated in CAMP. ROBO2 showed gene-level evidence of replication with asthma exacerbations despite ICS use in Europeans (minimum p-value = 1.44 x 10(-5)), but not in admixed individuals. The association of PDE10A-T with ICS response described by a previous study was validated. This study suggests that ROBO2 could be a potential novel locus for ICS response in Europeans.

Item Type: Article
Uncontrolled Keywords: GENOME-WIDE ASSOCIATION; BRONCHODILATOR RESPONSE; GENETIC-VARIATION; EXACERBATIONS; ROUNDABOUT; CHILDREN; SLIT2; PHARMACOGENOMICS; CHEMOTAXIS; PREDICTORS; childhood asthma; exacerbations; forced expiratory volume in one second; genome-wide association study; inhaled corticosteroids; single nucleotide polymorphism
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Kinder- und Jugendmedizin
Depositing User: Dr. Gernot Deinzer
Date Deposited: 04 Oct 2022 09:44
Last Modified: 04 Oct 2022 09:44
URI: https://pred.uni-regensburg.de/id/eprint/48221

Actions (login required)

View Item View Item